Skip to main content

Featured

Washington Presses Israel to Halt Strikes on Iran’s Energy Network

  Smoke rises in Sharjah, following reports of Iranian attacks after United States and Israel strikes on Iran, in Sharjah, United Arab Emirates, March 1, 2026. The United States has urged Israel to stop its ongoing attacks on Iran’s energy infrastructure, according to multiple reports citing senior U.S. and Israeli officials. Key Developments U.S. officials delivered the request at high political levels and directly to IDF Chief of Staff Eyal Zamir.  The Trump administration outlined several strategic concerns: A desire to maintain the possibility of future cooperation with Iran’s oil sector after the conflict. Fears that continued strikes could harm Iranian civilians.  Warnings that Iran might retaliate with large-scale attacks on Gulf energy infrastructure, a scenario described as a potential “doomsday option.”  Context The request marks a rare moment in which Washington is attempting to restrain Israeli military actions, despite the two nations having ...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment